Inovio Pharmaceuticals Inc (INO) Event May 10, 2022, 00:00 UTC (47% Neutral) INOVIO PHARMACEUTICALS, INC. (INO) Reports 45% Loss Increase for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:32 a.m. 🏢 Inovio Pharmaceuticals Inc (INO) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-10 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-79.10M $-54.40M $-24.70M -45.40% 📈 Total Assets $495.94M $445.51M $50.43M +11.32% 📈 Total Liabilities $96.27M $90.43M $5.85M +6.46% 📉 Stockholders' Equity $581.61M $-265.71K $581.87M +218989.21% 📈 Operating Income/Loss $-52.55M $-71.73M $19.18M +26.74% 📉 R&D Expense $39.04M $55.98M $-16.93M -30.25% 📈 Earningspersharebasic $-0.27 $-0.36 $0.09 +25.00% 📈 Earningspersharediluted $-0.27 $-0.36 $0.09 +25.00% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Inovio Pharmaceuticals Inc (INO) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document